Rockland Immunochemcials to Market LIMR's Cell Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Rockland Immunochemicals said today that it will market LIMR Development's cellular assays for research purposes.

The alliance builds on an earlier agreement between Gilbertsville, Pa.-based Rpckland and LIMR, which is a business development subsidiary of the Lankenau Institute for Medical Research.

Under the new agreement, Rockland will sell LIMR's CellCountEZ, OxPhos, RadDose, and Intracellular ThiolEZ assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.